enVVeno Medical (NVNO) Operating Leases (2019 - 2026)

enVVeno Medical's quarterly Operating Leases came in at $207000.0 in Q1 2026, down 66.01% year-on-year from $609000.0 in Q1 2025, and down 33.23% quarter-over-quarter from $310000.0 in Q4 2025.

enVVeno Medical has reported Operating Leases for 8 years, with the latest figure at $207000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Operating Leases fell 66.01% year-over-year to $207000.0; the trailing twelve-month figure through Mar 2026 stood at $207000.0 (down 66.01% YoY), and the FY2025 full-year result was $310000.0, down 55.71% from the prior year.
  • Operating Leases for Q1 2026 stood at $207000.0, down from $310000.0 in the prior quarter.
  • The five-year high for Operating Leases was $1.6 million in Q1 2022, with the low at $207000.0 in Q1 2026.
  • Average Operating Leases over 5 years is $958588.2, with a median of $973000.0 recorded in 2024.
  • Year-over-year, Operating Leases jumped 1742.0% in 2022 and tumbled 66.01% in 2026.
  • Tracing NVNO's Operating Leases over 5 years: stood at $1.4 million in 2022, then retreated by 24.11% to $1.1 million in 2023, then slumped by 34.21% to $700000.0 in 2024, then plunged by 55.71% to $310000.0 in 2025, then tumbled by 33.23% to $207000.0 in 2026.
  • The last three Operating Leases figures came in at $207000.0 (Q1 2026), $310000.0 (Q4 2025), and $505000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 enVVeno Medical 6.99 Mn 6.99 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 207,000.00
Dec 31, 2025 310,000.00
Sep 30, 2025 505,000.00
Jun 30, 2025 505,000.00
Mar 31, 2025 609,000.00
Dec 31, 2024 700,000.00
Sep 30, 2024 791,000.00
Jun 30, 2024 882,000.00
Mar 31, 2024 973,000.00
Dec 31, 2023 1.06 Mn
Sep 30, 2023 1.15 Mn
Jun 30, 2023 1.21 Mn
Mar 31, 2023 1.32 Mn
Dec 31, 2022 1.40 Mn
Sep 30, 2022 1.48 Mn
Jun 30, 2022 1.56 Mn
Mar 31, 2022 1.64 Mn
Dec 31, 2021 1.72 Mn
Sep 30, 2021 332,297.00
Jun 30, 2021 84,582.00
Mar 31, 2021 489,398.00
Dec 31, 2020 253,746.00
Sep 30, 2020 640,119.00
Jun 30, 2020 712,291.00
Mar 31, 2020 790,323.00
Dec 31, 2019 567,948.00
Sep 30, 2019 651,842.00
Jun 30, 2019 989,253.00
Mar 31, 2019 784,462.00